Good News! Turns Out the Earth Will Never Be Swallowed by the Sun
Good News! Turns Out the Earth Will Never Be Swallowed by the Sun Read More »
Category Added in a WPeMatico Campaign
Good News! Turns Out the Earth Will Never Be Swallowed by the Sun Read More »
Startup news and updates: Daily roundup (July 6, 2026) Read More »
Nvidia can barely sell its best chips in China. A crop of local challengers is racing to fill the gap. One of them just raised nearly $900m to speed up. Shanghai Biren Technology is selling HK$7 billion (about $892.5m) of new shares to boost GPU production. That is according to the South China Morning Post. […]
This story continues at The Next Web
China’s Biren raises $892M to build GPUs that can take on Nvidia at home Read More »
NYT Mini crossword answers, hints for July 6, 2026 Read More »
Google’s John Mueller responded to an SEO using LLMs-Author.txt to separate themself from others with the same name.
The post Google Answers Question About LLMs-Author.txt For SEO appeared first on Search Engine Journal.
Google Answers Question About LLMs-Author.txt For SEO via @sejournal, @martinibuster Read More »
ICE’s Internal Watchdog Is Now Investigating Online Critics Read More »
Nvidia’s next flagship AI machine has hit a wall, and the culprit is a single circuit board. The Kyber rack meant to house its 2027 Rubin Ultra chips has slipped to 2028. Research firm SemiAnalysis flagged the delay, and CNBC reported it. Kyber is not a chip. It is a server cabinet. It packs 144 […]
This story continues at The Next Web
Nvidia’s Kyber AI rack slips to 2028, and one circuit board is to blame Read More »
Kunal Kapoor launches MetaGO, a doctor-led metabolic health platform Read More »
Novartis has agreed to buy Myricx Bio, a small British oncology company, for up to $1.5bn, adding an early-stage but potentially significant technology to a cancer pipeline the industry keeps racing to expand. The Swiss group will pay $1.1bn upfront, with up to $400m more tied to milestones, in a deal that fits the pattern […]
This story continues at The Next Web
Novartis buys UK biotech Myricx for up to $1.5bn to chase a new cancer-drug class Read More »
What if the Universe Isn’t as Uniform as Scientists Think? Read More »